QVT Financial

Type

Venture Capital

Status

Active

Location

New York, United States

Total investments

25

Average round size

56M

Portfolio companies

20

Rounds per year

1.19

Lead investments

3

Follow on index

0.20

Exits

14

Stages of investment
Private EquityEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyPharmaceuticalsHealth CareMedicalLife SciencePharmaceuticalTherapeuticsBiopharmaClinical TrialsProduct Research

Summary

QVT Financial appeared to be the VC, which was created in 2003. The venture was found in North America in United States. The main department of described VC is located in the New York.

The standard case for the fund is to invest in rounds with 7-8 partakers. Despite the QVT Financial, startups are often financed by Sofinnova Partners, Gimv, Auriga Partners. The meaningful sponsors for the fund in investment in the same round are Venrock, Three Arch Partners, Foresite Capital. In the next rounds fund is usually obtained by Flagship Pioneering, Viking Global Investors, Three Arch Partners.

We also calculated 3 valuable employees in our database.

The average startup value when the investment from QVT Financial is more than 1 billion dollars. The high activity for fund was in 2014. The higher amount of exits for fund were in 2015. The usual things for fund are deals in the range of 50 - 100 millions dollars. The real fund results show that this VC is 14 percentage points less often commits exit comparing to other companies. Opposing the other organizations, this QVT Financial works on 40 percentage points more the average amount of lead investments. The fund is constantly included in less than 2 investment rounds annually.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight AveXis, Roivant Sciences, Adaptimmune. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little. Among the most popular fund investment industries, there are Broadcasting, Content.

Show more

Investor highlights

Industry focus
Biotech/Life SciencesHealthcareEnergyLogisticsFintech Show 1 more

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
25
Lead investments
3
Exits
14
Rounds per year
1.19
Follow on index
0.20
Investments by industry
  • Biotechnology (20)
  • Health Care (10)
  • Biopharma (8)
  • Therapeutics (7)
  • Medical (7)
  • Show 23 more
Investments by region
  • United States (19)
  • United Kingdom (2)
  • Canada (1)
  • France (1)
  • Israel (1)
Peak activity year
2006
Number of Unicorns
1
Number of Decacorns
1
Number of Minotaurs
2

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
16
Avg. valuation at time of investment
352M
Group Appearance index
0.92
Avg. company exit year
10
Avg. multiplicator
1.02
Strategy success index
0.80

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Acceleron Pharma 01 Oct 2007 Biotechnology, Health Care, Manufacturing, Medical, Pharmaceutical Late Stage Venture 31M United States, Massachusetts, Cambridge
Active Surfaces 13 May 2024 Renewable Energy, Solar Seed 5M United States, Massachusetts, Salem
AITREAT 01 Oct 2016 Robotics, Medical Device, Medical Seed 200K Central, Singapore, Singapore
1Huddle 15 Mar 2017 Educational Software, Educational and Training Services (B2C), Social/Platform Software, Human Resources, SaaS, Enterprise Software, Training, Gamification Seed 500K United States, New York

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.